201 related articles for article (PubMed ID: 18574082)
21. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.
Alhazzani W; Lim W; Jaeschke RZ; Murad MH; Cade J; Cook DJ
Crit Care Med; 2013 Sep; 41(9):2088-98. PubMed ID: 23782973
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
[TBL] [Abstract][Full Text] [Related]
23. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
Wein L; Wein S; Haas SJ; Shaw J; Krum H
Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation in patients with cancer: an overview of reviews.
Akl EA; Muti P; Schünemann HJ
Pol Arch Med Wewn; 2008 Apr; 118(4):183-93. PubMed ID: 18575417
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
27. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.
Akl EA; Terrenato I; Barba M; Sperati F; Muti P; Schünemann HJ
Thromb Haemost; 2008 Dec; 100(6):1176-80. PubMed ID: 19132245
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
29. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
[TBL] [Abstract][Full Text] [Related]
30. Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery.
Akl EA; Kahale LA; Schünemann HJ
JAMA; 2015 Apr; 313(13):1364-5. PubMed ID: 25849181
[TBL] [Abstract][Full Text] [Related]
31. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials.
Bump GM; Dandu M; Kaufman SR; Shojania KG; Flanders SA
J Hosp Med; 2009 May; 4(5):289-97. PubMed ID: 19504490
[TBL] [Abstract][Full Text] [Related]
32. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis.
Vidal E; Sharathkumar A; Glover J; Faustino EV
J Thromb Haemost; 2014 Jul; 12(7):1096-109. PubMed ID: 24801495
[TBL] [Abstract][Full Text] [Related]
33. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.
Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP
BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin.
Tao E; Luo YL; Tao Z; Wan L
Medicine (Baltimore); 2020 Jan; 99(3):e18729. PubMed ID: 32011451
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review.
Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Bdair F; Schünemann HJ
Cancer; 2008 Oct; 113(7):1685-94. PubMed ID: 18720360
[TBL] [Abstract][Full Text] [Related]
36. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
[TBL] [Abstract][Full Text] [Related]
37. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.
Fagarasanu A; Alotaibi GS; Hrimiuc R; Lee AY; Wu C
Ann Surg Oncol; 2016 May; 23(5):1422-30. PubMed ID: 26887853
[TBL] [Abstract][Full Text] [Related]
38. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy with heparin in patients with lung cancer without indication for anticoagulants: A systematic review of the literature with meta-analysis.
Yu Y; Lv Q; Zhang B; Lan F; Dai Y
J Cancer Res Ther; 2016 Oct; 12(Supplement):37-42. PubMed ID: 27721250
[TBL] [Abstract][Full Text] [Related]
40. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
